Keyphrases
Oral Antibiotics
56%
Staphylococcus Aureus Bacteremia
50%
Dalbavancin
50%
Arcanobacterium Haemolyticum
50%
Pharyngotonsillitis
50%
Public Profile
50%
People Who Inject Drugs
50%
Texas USA
50%
Solid Organ Transplant Recipients
50%
Antifungal Agents
50%
Pharyngitis
50%
Invasive Fungal Infection
50%
Ceftolozane-tazobactam
50%
Cytomegalovirus Infection
50%
Risk Factor Management
50%
Hydroxychloroquine
50%
Houston
50%
Safety-net Hospital
50%
Hematological Malignancies
50%
Acute Care
50%
Control Algorithm
50%
Clinical Outcomes
50%
Antimicrobial
50%
Ventricular Assist Device Infection
50%
Older Adults
50%
Left Ventricular Assist Device
50%
Clinical Microbiology
50%
Policy Decisions
50%
Risk Outcomes
50%
Clinical Decision-making
50%
COVID-19
50%
Pseudotumor
50%
Mass-like
50%
Masquerade
50%
Clinical Characteristics
50%
Disease Impact
50%
Pyogenic Liver Abscess
50%
Novel Agents
50%
Inpatient Facility
50%
Pharyngeal Swab
33%
Penicillin
33%
Solid Organ Transplant
33%
Novel Antifungals
33%
Uncommon Presentation
25%
Intravenous Antibiotics
25%
Standard of Care
25%
High Index of Suspicion
25%
Cytomegalovirus Disease
25%
Advanced Cancer
25%
Organ Transplantation
25%
Medicine and Dentistry
Device Infection
100%
Left Ventricular Assist Device
100%
Diseases
80%
Antibiotic Therapy
75%
Antibiotics
62%
Surgery
56%
Infection
54%
Clinical Decision Making
50%
Hydroxychloroquine
50%
Arcanobacterium haemolyticum
50%
Cytomegalovirus Infection
50%
Staphylococcal Bacteremia
50%
Hematologic Malignancy
50%
Emergency Care
50%
Pseudotumor
50%
COVID-19
50%
Dalbavancin
50%
Tazobactam
50%
Ceftolozane
50%
Systematic Review
50%
Antiinfective Agent
50%
Throat Culture
50%
Pharyngitis
50%
Pyogenic Liver Abscess
50%
Penicillin
50%
Hazard Ratio
50%
Bloodstream Infection
41%
Clinician
35%
Decision Making
35%
Debridement
33%
Staphylococcus Aureus
28%
Acute Leukemia
25%
Cytomegalovirus
25%
Organ Transplantation
25%
Peritonsillar Abscess
25%
Advanced Cancer
25%
Exanthem
25%
Sepsis
25%
Exudate
25%
Sore Throat
25%
Macrolide
25%
Diagnosis
25%
Lemierre's Syndrome
25%
Antibiogram
25%
Hospital Mortality
17%
Congestive Heart Failure
14%
Combination Therapy
13%
Intensive Care Utilization
12%
Driveline Infection
12%
Adverse Event
12%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotics
62%
Systemic Mycosis
50%
Antifungal Agent
50%
Dalbavancin
50%
Tazobactam
50%
Ceftolozane
50%
Staphylococcal Bacteremia
50%
Device Infection
50%
Antiinfective Agent
50%
Bloodstream Infection
41%
Infection
37%
Staphylococcus Aureus
28%
Antibiotic Therapy
14%
Immunosuppressive Agent
12%
Pharmacodynamics
12%
Drug-Drug Interaction
12%
Clinical Trial
12%
Adverse Event
12%
Driveline Infection
12%
Pharmacokinetics
12%
Pseudomonas aeruginosa
10%
Epidural Abscess
7%
Bacterial Arthritis
7%
Intravenous Therapy
7%
Bacterial Endocarditis
7%
Spondylitis
7%
Corynebacterium striatum
6%
Skin Flora
6%
Congestive Heart Failure
6%
Gram Negative Bacterium
5%
Hospital Mortality
5%
Retrospective Study
5%
Lactam
5%
Combination Therapy
5%
Bacterial Pneumonia
5%
Penicillinase
5%
Diseases
5%
